Revenue: The sum of all revenue fields included for a company's operating activities.
COSCIENS Biopharma Inc. (CSCIF) had Revenue of $1.48M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$1.48M |
$-1.82M |
|
$0.86M |
|
$0.62M |
|
$3.81M |
|
$-2.32M |
|
$0.50M |
|
$-1.82M |
|
$-1.82M |
|
$-1.82M |
|
$-1.82M |
|
$-1.82M |
|
$-1.82M |
|
$-2.32M |
|
$-2.03M |
|
3.18M |
|
3.18M |
|
$-0.57 |
|
$-0.57 |
|
| Balance Sheet Financials | |
$13.84M |
|
$9.89M |
|
$10.02M |
|
$23.86M |
|
$3.98M |
|
-- |
|
$14.80M |
|
$18.78M |
|
$5.08M |
|
$5.08M |
|
$5.08M |
|
3.18M |
|
| Cash Flow Statement Financials | |
$-7.00M |
|
$-0.66M |
|
$-0.39M |
|
$16.39M |
|
$8.52M |
|
$-7.87M |
|
$-0.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
41.87% |
|
-156.64% |
|
-156.64% |
|
-- |
|
-122.66% |
|
-122.66% |
|
$-7.66M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.49 |
|
0.92 |
|
97.40 |
|
-35.81% |
|
-35.81% |
|
-7.62% |
|
-35.81% |
|
$1.60 |
|
$-2.41 |
|
$-2.20 |
|